Tumors are molecularly diverse and each tumor is an evolutionary system on its own. The inter- and intra-tumor heterogeneity influence the clinical and biological behavior of cancers and has important implications in tumor progression, metastatic process and therapy resistance.

The oncogenomics lab is interested in the understanding of tumor evolutionary dynamics and the discovery of novel biomarkers and therapeutic targets in cancer. We leverage the abundance of 'omics' data derived from clinically annotated samples in computational frameworks to address challenges in precision medicine in cancer.

C. Ng

Group Members 2